Kasugai, Japan

Akio Kojima

This inventor holds 3 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1989-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akio Kojima. Retrieved from https://idiyas.com/inventor/akio-kojima-k291tox0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1989-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akio Kojima: Innovator in Organogermanium Compounds

Introduction

Akio Kojima is a notable inventor based in Kasugai, Japan. He has made significant contributions to the field of organogermanium compounds, with a focus on their applications in immunity adjustment and treatment of hepatitis. His innovative work has led to the development of several patents that highlight his expertise and dedication to advancing medical science.

Latest Patents

Kojima holds 3 patents related to his research. His latest patents include a composition containing an organogermanium compound, which is represented by a specific formula. This composition serves as an immunity adjusting agent and is designed to treat hepatitis using the germanium derivative. The detailed formulation includes various components such as hydrogen, alkyl, and phenyl groups, showcasing the complexity and potential of his inventions.

Career Highlights

Throughout his career, Akio Kojima has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has contributed to groundbreaking research and development. His work has not only advanced the understanding of organogermanium compounds but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Kojima has collaborated with esteemed colleagues such as Kiichi Sawai and Masayasu Kurono. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective research.

Conclusion

Akio Kojima's contributions to the field of organogermanium compounds exemplify his commitment to innovation and medical advancement. His patents and collaborations reflect a dedication to improving health outcomes through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…